软体外骨骼对不完全性脊髓损伤患者日常生活步态表现的影响:随机对照试验研究方案
本研究为双臂开放标签随机对照试验,计划纳入34例慢性不完全性脊髓损伤患者,按1:1随机分为Myosuit干预组和常规程序对照组,主要结局为活动监测器评估的每日步行时间,次要结局包括步态能力、可用性及成本效果。
要点
- 首个评估Myosuit软体外骨骼对不完全性脊髓损伤患者日常生活步态表现影响的随机对照试验。
- 干预组接受5次Myosuit步态训练后在家使用6周,对照组先接受4次常规步态训练后在家6周,之后交叉接受Myosuit程序。
- 主要结局为基线和家庭期第1、3、6周活动监测器评估的每日步行时间。
核心结论
- 本研究旨在测试软体外骨骼Myosuit对不完全性脊髓损伤患者日常生活步态表现的影响,并评估其对步态能力和可用性的影响及短期成本效果。
研究设计与样本
- 双臂开放标签随机对照试验,计划纳入34例慢性不完全性脊髓损伤患者,按1:1随机分为干预组和对照组。
- 干预组在Sint Maartenskliniek接受5次Myosuit步态训练,之后在家使用Myosuit 6周;对照组先接受4次步态训练后在家6周,随后交叉接受Myosuit程序。
- 主要结局为基线和家庭期第1、3、6周活动监测器评估的每日步行时间;次要结局包括10MWT、6MWT、SCI-FAP、D-SUS、D-QUEST问卷及EQ-5D-5L评估的成本与效果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with incomplete spinal cord injury (iSCI) often have gait impairments that negatively affect daily life gait performance (i.e., ambulation in the home and community setting) and quality of life. They may benefit from light-weight lower extremity exosuits that assist in walking, such as the Myosuit (MyoSwiss AG, Zurich, Switzerland). A previous pilot study showed that participants with various gait disorders increased their gait speed with the Myosuit in a standardized environment. However, the effect of a soft exosuit on daily life gait performance in people with iSCI has not yet been evaluated. OBJECTIVE: The primary study objective is to test the effect of a soft exosuit (Myosuit) on daily life gait performance in people with iSCI. Second, the effect of Myosuit use on gait capacity and the usability of the Myosuit in the home and community setting will be investigated. Finally, short-term impact on both costs and effects will be evaluated. METHODS: This is a two-armed, open label, randomized controlled trial (RCT). Participants will be randomized (1:1) to the intervention group (receiving the Myosuit program) or control group (initially receiving the conventional program). Thirty-four people with chronic iSCI will be included. The Myosuit program consists of five gait training sessions with the Myosuit at the Sint Maartenskliniek. Thereafter, participants will have access to the Myosuit for home use during 6 weeks. The conventional program consists of four gait training sessions, followed by a 6-week home period. After completing the conventional program, participants in the control group will subsequently receive the Myosuit program. The primary outcome is walking time per day as assessed with an activity monitor at baseline and during the first, third, and sixth week of the home periods. Secondary outcomes are gait capacity (10MWT, 6MWT, and SCI-FAP), usability (D-SUS and D-QUEST questionnaires), and costs and effects (EQ-5D-5L). DISCUSSION: This is the first RCT to investigate the effect of the Myosuit on daily life gait performance in people with iSCI. TRIAL REGISTRATION: Clinicaltrials.gov NCT05605912. Registered on November 2, 2022.
引用
- Visch L, Groen BE, Geurts ACH, et al. Effect of a soft exosuit on daily life gait performance in people with incomplete spinal cord injury: study protocol for a randomized controlled trial. Trials. 2024. PMID: 39242508. doi:10.1186/s13063-024-08412-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。